These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8821899)

  • 21. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1389-93. PubMed ID: 12629134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein anabolic action of insulin, growth hormone and insulin-like growth factor I.
    Russell-Jones DL; Umpleby M
    Eur J Endocrinol; 1996 Dec; 135(6):631-42. PubMed ID: 9025701
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus.
    Cheetham TD; Jones J; Taylor AM; Holly J; Matthews DR; Dunger DB
    Diabetologia; 1993 Jul; 36(7):678-81. PubMed ID: 8359587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in puberty.
    Lancet; 1991 May; 337(8752):1259-60. PubMed ID: 1674069
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in childhood onset diabetes.
    Shield JP; Baum JD
    Arch Dis Child; 1998 Apr; 78(4):391-4. PubMed ID: 9623411
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetes in puberty.
    Dunger DB
    Arch Dis Child; 1992 May; 67(5):569-70. PubMed ID: 1599288
    [No Abstract]   [Full Text] [Related]  

  • 27. Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes.
    Usala AL; Madigan T; Burguera B; Sinha MK; Caro JF; Cunningham P; Powell JG; Butler PC
    N Engl J Med; 1992 Sep; 327(12):853-7. PubMed ID: 1508245
    [No Abstract]   [Full Text] [Related]  

  • 28. Childhood and adolescent diabetes.
    Dunger DB; Regan FM; Acerini CL
    Endocr Dev; 2005; 9():107-120. PubMed ID: 15879693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group.
    Thrailkill KM; Quattrin T; Baker L; Kuntze JE; Compton PG; Martha PM
    Diabetes Care; 1999 Apr; 22(4):585-92. PubMed ID: 10189536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile.
    Quattrin T; Thrailkill K; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Giltinan D; Gesundheit N; Martha P
    Diabetes Care; 1997 Mar; 20(3):374-80. PubMed ID: 9051390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor (IGF)-I gene deletion.
    Camacho-Hübner C; Woods KA; Clark AJ; Savage MO
    Rev Endocr Metab Disord; 2002 Dec; 3(4):357-61. PubMed ID: 12424437
    [No Abstract]   [Full Text] [Related]  

  • 32. Gender and hormonal regulation of growth.
    Rogol AD
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1259-65. PubMed ID: 15506071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor type 1--friend or foe?
    Knott RM
    Br J Ophthalmol; 1998 Jul; 82(7):719-20. PubMed ID: 9924357
    [No Abstract]   [Full Text] [Related]  

  • 34. Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes.
    Cummings EA; Sochett EB; Dekker MG; Lawson ML; Daneman D
    Diabetes; 1998 Aug; 47(8):1341-6. PubMed ID: 9703337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin therapy in the last decade. A pediatric perspective.
    Santiago JV
    Diabetes Care; 1993 Dec; 16 Suppl 3():143-54. PubMed ID: 8299471
    [No Abstract]   [Full Text] [Related]  

  • 36. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus.
    Dunger DB; Cheetham TD; Crowne EC
    Metabolism; 1995 Oct; 44(10 Suppl 4):119-23. PubMed ID: 7476304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frailty and the somatopause.
    Martin F
    Growth Horm IGF Res; 1999 Feb; 9(1):3-10. PubMed ID: 10207502
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolic impact of puberty on the course of type 1 diabetes.
    Acerini CL; Williams RM; Dunger DB
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S19-25. PubMed ID: 11787432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.